Mengqing Cao
Jiaxing, 314000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Early On-Treatment Expansion of Peripheral γδT Cells as a Noninvasive Biomarker of Response to Programmed Death-1 Inhibitor Therapy in Advanced Non-Small Cell Lung Cancer.
Journal: Cancer management and research
Published: May 25, 2026
Case Report: Lorlatinib combined with chemotherapy and anti-angiogenic therapy shows promising efficacy in an ALK gene fusion lung adenocarcinoma patient with iruplinalkib resistance.
Journal: Frontiers in pharmacology
Published: May 09, 2026
Efficacy and Safety of Low-Dose Trimethoprim-Sulfamethoxazole (TMP-SMZ) for the Prevention of Pneumocystis jirovecii pneumonia (PJP) in Non-HIV, Non-Transplant Immunosuppressed Patients: A Real-World Cohort Study.
Journal: Infection and drug resistance
Published: June 25, 2025
Study on the application of microfluidic-based in vitro diagnostic technology in pathogenic detection of respiratory tract infections.
Journal: Journal of translational medicine
Published: July 03, 2024
The Effects of Budesonide Inhalation Treatment on the Expression Levels of Serum IL-6, TGF-β1, and IgE and Pulmonary Function in Patients with Cough Variant Asthma and an Evaluation of Treatment Efficacy.
Journal: International journal of general medicine
Published: December 20, 2023
The Prognostic Value and Potential Mechanism of Tumor-Nutrition-Inflammation Index and Genes in Patients with Advanced Lung Cancer.
Journal: International journal of clinical practice
Published: March 15, 2023
Cinchonine exerts anti-tumor and immunotherapy sensitizing effects in lung cancer by impairing autophagic-lysosomal degradation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 01, 2023
Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy.
Journal: Frontiers in oncology
Published: September 08, 2022
Construction of a predictive model for immunotherapy efficacy in lung squamous cell carcinoma based on the degree of tumor-infiltrating immune cells and molecular typing.
Journal: Journal of translational medicine
Published: May 02, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026